Pfizer and Western Oncolytics announce immuno-oncology research collaboration
Pfizer and Western Oncolytics announced they have entered into a development collaboration, license and option agreement to advance Western Oncolytics’ novel oncolytic vaccinia virus, WO-12. Oncolytic viruses are viruses engineered to kill cancer cells while sparing healthy cells. July 28, 2016